Zobrazeno 1 - 10
of 59
pro vyhledávání: '"H. Terpstra"'
Autor:
Elisabeth Brouwer, Kornelis S M van der Geest, Maria Sandovici, Yannick van Sleen, Janneke H Terpstra, Marieke van der Heiden, Debbie van Baarle, Rosanne D Reitsema, Idil Esen, Elisabeth Raveling-Eelsing, Thomas Lieber, Annemarie M Buisman
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objectives Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are overlapping autoinflammatory diseases affecting people over 50 years. The diseases are treated with immunosuppressive drugs such as prednisolone, methotrexate, leflunomide and
Externí odkaz:
https://doaj.org/article/76c7e8068fd342b7b2e4a6545ce65972
Autor:
Suzanne Arends, Frans G M Kroese, Arjan Vissink, Hendrika Bootsma, Gwenny M Verstappen, Liseth de Wolff, Annie Visser, Yannick van Sleen, Hella-Marie Heiermann, Janneke H Terpstra, Dimitri A Diavatopoulos, Marieke van der Heiden, Debbie van Baarle
Publikováno v:
RMD Open, Vol 8, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/7e22ce1fb96a4259bbebb1a661ca4a0b
Autor:
Tobit D. Steinmetz, Liseth de Wolff, Janneke H. Terpstra, Annie Visser, Hendrika Bootsma, Frans G.M. Kroese, Gwenny M. Verstappen
Publikováno v:
Clinical and Experimental Rheumatology, 40(12), 2338-2343. CLINICAL & EXPER RHEUMATOLOGY
Objective The peripheral lymphocyte compartment of patients with primary Sjögren’s syndrome (pSS) differs strongly from healthy individuals. Whether this altered lymphocyte composition also changes abnormally during immune reactions, especially by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::311e0cd80ef8a19cf8e2b78c31546310
https://doi.org/10.55563/clinexprheumatol/1iaqnu
https://doi.org/10.55563/clinexprheumatol/1iaqnu
Autor:
Gwenny M Verstappen, Liseth de Wolff, Suzanne Arends, Hella-Marie Heiermann, Yannick van Sleen, Annie Visser, Janneke H Terpstra, Dimitri A Diavatopoulos, Marieke van der Heiden, Arjan Vissink, Debbie van Baarle, Frans G M Kroese, Hendrika Bootsma
Publikováno v:
BMJ Open, 8(1):e002265. BMJ PUBLISHING GROUP
Rheumatic & Musculoskeletal Diseases Open, 8, 1
Rheumatic & Musculoskeletal Diseases Open, 8
Annals of the Rheumatic Diseases, 81, 652-653. BMJ PUBLISHING GROUP
Rheumatic & Musculoskeletal Diseases Open, 8, 1
Rheumatic & Musculoskeletal Diseases Open, 8
Annals of the Rheumatic Diseases, 81, 652-653. BMJ PUBLISHING GROUP
ObjectivesTo evaluate humoral and cellular immune responses and adverse events (AEs) after COVID-19 vaccination in patients with primary Sjögren’s syndrome (pSS) compared to healthy controls (HC), and disease activity following vaccination in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cf4a1e0f80b77deceb905f15a241c8c
https://research.rug.nl/en/publications/870e2815-319a-4304-a2eb-8bcdf68a07f3
https://research.rug.nl/en/publications/870e2815-319a-4304-a2eb-8bcdf68a07f3
Autor:
G. M. Verstappen, L. De Wolff, S. Arends, H. M. Heiermann, Y. Van Sleen, A. Visser, J. H. Terpstra, D. Diavatopoulos, M. Van der Heiden, A. Vissink, D. Van Baarle, F. G. M. Kroese, H. Bootsma
Publikováno v:
Annals of the Rheumatic Diseases. 81:652-653
BackgroundPatients with primary Sjögren’s syndrome (pSS) worry about the effectiveness and safety of COVID-19 vaccination. pSS is characterized by B-cell hyperactivity, and previous influenza vaccination studies showed that pSS patients generate h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a2bbf166671511276a7698ab72f977b
https://doi.org/10.1136/annrheumdis-2022-eular.1598
https://doi.org/10.1136/annrheumdis-2022-eular.1598
Autor:
Yannick van Sleen, Kornelis S M van der Geest, Rosanne D Reitsema, Idil Esen, Janneke H Terpstra, Elisabeth Raveling-Eelsing, Marieke van der Heiden, Thomas Lieber, Annemarie M Buisman, Debbie van Baarle, Maria Sandovici, Elisabeth Brouwer
Publikováno v:
BMJ Open, 8(2):002479. BMJ PUBLISHING GROUP
ObjectivesGiant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are overlapping autoinflammatory diseases affecting people over 50 years. The diseases are treated with immunosuppressive drugs such as prednisolone, methotrexate, leflunomide and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d88b43e15607fcb0d9d2a9899289b260
https://doi.org/10.1136/rmdopen-2022-002479
https://doi.org/10.1136/rmdopen-2022-002479
Autor:
Y. Van Sleen, K. Van der Geest, R. Reitsema, I. Esen, J. H. Terpstra, E. Raveling-Eelsing, M. Van der Heiden, J. Jansen, A. Buisman, D. Van Baarle, M. Sandovici, E. Brouwer
Publikováno v:
Annals of the Rheumatic Diseases. 81:373.1-373
BackgroundGiant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are overlapping autoinflammatory diseases affecting people over 50 years. The diseases are treated with immunosuppressive drugs such as prednisolone, methotrexate, leflunomide and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06b5b4488bd5f52f5f7e994f66dddbb3
https://doi.org/10.1136/annrheumdis-2022-eular.1121
https://doi.org/10.1136/annrheumdis-2022-eular.1121
Autor:
Frans G. M. Kroese, Bert van der Vegt, Hendrika Bootsma, Fred K L Spijkervet, Janneke H. Terpstra, Xiaoyan Wang, Arjan Vissink, Sarah Pringle
Publikováno v:
Rheumatology, 59(10), 3003-3013. Oxford University Press
Rheumatology (Oxford, England)
Rheumatology (Oxford, England)
ObjectiveSalivary gland (SG) progenitor cells (SGPCs) maintain SG homeostasis. We have previously shown that in primary Sjögren’s syndrome (pSS), SGPCs are likely to be senescent, and may underpin SG dysfunction. This study assessed the extent of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6848e0b03e92cdf2ad96675498135fc8
https://research.rug.nl/en/publications/8bfb387d-fe61-405d-8630-29310d4387a0
https://research.rug.nl/en/publications/8bfb387d-fe61-405d-8630-29310d4387a0
Autor:
Gwenny M Verstappen, Julie Carman, Arathi Krishnakumar, Jolien F van Nimwegen, Frans G. M. Kroese, Lu Gao, Amy Truong, Sarah Pringle, Silvia C Liefers, Stefan Kirov, Vishal Patel, Hendrika Bootsma, Ashok Dongre, Sarah Hu, Aiqing He, Arjan Vissink, Janneke H. Terpstra
Publikováno v:
Poster Presentations.
Background Patients with primary Sjogren’s syndrome (pSS) present with heterogeneous clinical symptoms and immune dysregulation. How immune dysregulation in SS arises is poorly understood, which hampers development of effective therapies. Identific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::125401c6e66a8620f864ba8fb96305e6
https://doi.org/10.1136/annrheumdis-2019-eular.3148
https://doi.org/10.1136/annrheumdis-2019-eular.3148